Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)

Technology appraisal
Reference number: TA793
Published: 08 June 2022

History

Invitation to participate

Final scope (PDF 184 KB)

Published:

10 June 2021
Final stakeholder list (PDF 178 KB)

Published:

10 June 2021
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 289 KB)

Published:

10 June 2021
Equality impact assessment (Scoping) (PDF 134 KB)

Published:

10 June 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 183 KB)

Published:

24 November 2020
Draft matrix post referral (PDF 166 KB)

Published:

24 November 2020